Pharmacokinetic endpoints: if the research objective includes PK characterisation, build in LC-MS quantification of serum peptide at multiple timepoints to generate a concentration-time curve
VEGFR2, FAK-Paxillin, and Nitric Oxide Pathways: Tracking the cellular adhesion and signaling mechanics driven by BPC-157
In the hippocampus of individuals with Alzheimer's disease (AD), the expression of PGC-1, NRF1, NRF2, and TFAM is significantly decreased, indicating impaired mitochondrial biogenesis (203)
Chille leads a team of wellness professionals who integrate functional medicine, nutrigenomics, cellular and microbial medicine, peptide therapy, and advanced lab diagnostics to deliver highly personalized care